SLC25A17

Peroxisomal membrane protein PMP34 · O43808 · SLC25A17 on Sugi Atlas →

0 patent compounds predicted against SLC25A17, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC25A17 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Betaine and Peroxisome Biogenesis Disorders PHASE3COMPLETED
Acetylcarnitine and Insulin Sensitivity PHASE2COMPLETED
Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome PHASE1/PHASE2COMPLETED
Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI) PHASE2RECRUITING
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases nanCOMPLETED
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular Powerhouse) Dysfunction nanCOMPLETED
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Mitochondrial Dysfunction in Phelan-McDermid Syndrome nanCOMPLETED
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Assessing the Role of Mitochondrial Dysfunction in Primary Progressive Multiple Sclerosis nanUNKNOWN
Identification and Characterization of Monogenic Diabetes nanCOMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children nanWITHDRAWN
Lifestyle Intervention in Fatty Liver (NAFLD) nanUNKNOWN
The Natural History of Mitochondrial Diseases nanRECRUITING
Oxalate and Citrate in Humans - Response to Citrate nanRECRUITING
Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease nanNOT_YET_RECRUITING
Gastrostomy-Biliary Diversion: Innovative Management for Bile Canalicular Transport Disorders nanUNKNOWN
Characterization and Outcome of Children With Leukodystrophy: An Observational Study at Sohag University Hospital nanUNKNOWN
Multi-omics Study in Citrin Deficiency nanACTIVE_NOT_RECRUITING
Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
The Classification and Cause of Leukodystrophies of Unknown Cause nanCOMPLETED
Familial Partial Lipodystrophy Study nanCOMPLETED
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a SLC25A17 binder may also engage these)

ProteinNameSimilarity
O70579 1.000 O70579 →
Q6IZB5 0.952 Q6IZB5 →
Q9H2D1 0.944 Q9H2D1 →
Q8BMG8 0.942 Q8BMG8 →
O22261 0.942 O22261 →
Q95J75 0.941 Q95J75 →
Q922G0 0.937 Q922G0 →
Q5ZKP7 0.936 Q5ZKP7 →
Q5U680 0.935 Q5U680 →
Q96CQ1 0.932 Q96CQ1 →
Q66H23 0.932 Q66H23 →
Q9NYZ2 0.931 Q9NYZ2 →
Q6GLA2 0.930 Q6GLA2 →
Q287T7 0.929 Q287T7 →
A6QR09 0.927 A6QR09 →
P55916 0.927 P55916 →
Q9N2I9 0.926 Q9N2I9 →
O77792 0.924 O77792 →
P56499 0.923 P56499 →
Q9BSK2 0.922 Q9BSK2 →
Q6DG32 0.921 Q6DG32 →
Q9N2J1 0.921 Q9N2J1 →
Q3SZI5 0.921 Q3SZI5 →
Q9D6D0 0.920 Q9D6D0 →
Q9W720 0.920 Q9W720 →
Q1LZB3 0.920 Q1LZB3 →
Q70HW3 0.920 Q70HW3 →
Q9Z2B2 0.920 Q9Z2B2 →
P55851 0.919 P55851 →
Q5R5A8 0.919 Q5R5A8 →